메뉴 건너뛰기




Volumn 33, Issue 3, 2015, Pages 1201-1206

Overexpression of RhoGDI2 correlates with the progression and prognosis of pancreatic carcinoma

Author keywords

E cadherin; Pancreatic carcinoma; Prognosis; RhoGDI2

Indexed keywords

RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; UVOMORULIN; ARHGDIB PROTEIN, HUMAN; CADHERIN;

EID: 84921652792     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3707     Document Type: Article
Times cited : (18)

References (26)
  • 3
    • 44449178868 scopus 로고    scopus 로고
    • Rho GTPases in cancer cell biology
    • Vega FM and Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett 582:2093-2101, 2008.
    • (2008) FEBS Lett , vol.582 , pp. 2093-2101
    • Vega, F.M.1    Ridley, A.J.2
  • 4
    • 84855894667 scopus 로고    scopus 로고
    • Rho GTPases and cancer cell transendothelial migration
    • Reymond N, Riou P and Ridley AJ: Rho GTPases and cancer cell transendothelial migration. Methods Mol Biol 827:123-142, 2012.
    • (2012) Methods Mol Biol , vol.827 , pp. 123-142
    • Reymond, N.1    Riou, P.2    Ridley, A.J.3
  • 5
    • 79960706295 scopus 로고    scopus 로고
    • The 'invisible hand': Regulation of RHO GTPases by RHOGDIs
    • Garcia-Mata R, Boulter E and Burridge K: The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 12:493-504, 2011.
    • (2011) Nat Rev Mol Cell Biol , vol.12 , pp. 493-504
    • Garcia-Mata, R.1    Boulter, E.2    Burridge, K.3
  • 9
    • 84902678752 scopus 로고    scopus 로고
    • Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma
    • Yi B, Hu Y, Qin G, et al: Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma. Int J Mol Med 34:205-212, 2014.
    • (2014) Int J Mol Med , vol.34 , pp. 205-212
    • Yi, B.1    Hu, Y.2    Qin, G.3
  • 10
    • 84856088337 scopus 로고    scopus 로고
    • EMT and dissemination precede pancreatic tumor formation
    • Rhim AD, Mirek ET, Aiello NM, et al: EMT and dissemination precede pancreatic tumor formation. Cell 148:349-361, 2012.
    • (2012) Cell , vol.148 , pp. 349-361
    • Rhim, A.D.1    Mirek, E.T.2    Aiello, N.M.3
  • 11
    • 84860229851 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status
    • Kevans D, Wang LM, Sheahan K, et al: Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol 19:751-760, 2011.
    • (2011) Int J Surg Pathol , vol.19 , pp. 751-760
    • Kevans, D.1    Wang, L.M.2    Sheahan, K.3
  • 12
    • 84877858964 scopus 로고    scopus 로고
    • Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling
    • Matsuoka J, Yashiro M, Doi Y, et al: Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling. PLoS One 8:e62310, 2013.
    • (2013) PLoS One , vol.8 , pp. e62310
    • Matsuoka, J.1    Yashiro, M.2    Doi, Y.3
  • 13
    • 84875470847 scopus 로고    scopus 로고
    • Breast cancer: Circulating and dynamic EMT
    • Burgess DJ: Breast cancer: Circulating and dynamic EMT. Nat Rev Cancer 13:148, 2013.
    • (2013) Nat Rev Cancer , vol.13 , pp. 148
    • Burgess, D.J.1
  • 14
    • 45549107919 scopus 로고    scopus 로고
    • Invasion and metastasis models for studying RhoGDI2 in bladder cancer
    • Nitz MD, Harding MA and Theodorescu D: Invasion and metastasis models for studying RhoGDI2 in bladder cancer. Methods Enzymol 439:219-233, 2008.
    • (2008) Methods Enzymol , vol.439 , pp. 219-233
    • Nitz, M.D.1    Harding, M.A.2    Theodorescu, D.3
  • 15
    • 84856670062 scopus 로고    scopus 로고
    • Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma
    • Li X, Wang J, Zhang X, Zeng Y, Liang L and Ding Y: Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma. Ann Surg Oncol 19:145-153, 2012.
    • (2012) Ann Surg Oncol , vol.19 , pp. 145-153
    • Li, X.1    Wang, J.2    Zhang, X.3    Zeng, Y.4    Liang, L.5    Ding, Y.6
  • 16
    • 0027237511 scopus 로고
    • Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes
    • Scherle P, Behrens T and Staudt LM: Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci USA 90:7568-7572, 1993.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 7568-7572
    • Scherle, P.1    Behrens, T.2    Staudt, L.M.3
  • 17
    • 77954356790 scopus 로고    scopus 로고
    • Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis
    • Niu H, Li H, Xu C and He P: Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep 24:465-471, 2010.
    • (2010) Oncol Rep , vol.24 , pp. 465-471
    • Niu, H.1    Li, H.2    Xu, C.3    He, P.4
  • 18
    • 84859571571 scopus 로고    scopus 로고
    • Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer
    • Cho HJ, Baek KE, Kim IK, et al: Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. J Proteome Res 11:2355-2364, 2012.
    • (2012) J Proteome Res , vol.11 , pp. 2355-2364
    • Cho, H.J.1    Baek, K.E.2    Kim, I.K.3
  • 19
    • 2542606977 scopus 로고    scopus 로고
    • Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer
    • Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM and Frierson HF Jr: Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10:3800-3806, 2004.
    • (2004) Clin Cancer Res , vol.10 , pp. 3800-3806
    • Theodorescu, D.1    Sapinoso, L.M.2    Conaway, M.R.3    Oxford, G.4    Hampton, G.M.5    Frierson, H.F.6
  • 20
    • 34848854515 scopus 로고    scopus 로고
    • Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma
    • Ma L, Xu G, Sotnikova A, et al: Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol 139:217-223, 2007.
    • (2007) Br J Haematol , vol.139 , pp. 217-223
    • Ma, L.1    Xu, G.2    Sotnikova, A.3
  • 21
    • 23944518413 scopus 로고    scopus 로고
    • RhoGDI: Multiple functions in the regulation of Rho family GTPase activities
    • Dovas A and Couchman JR: RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 390:1-9, 2005.
    • (2005) Biochem J , vol.390 , pp. 1-9
    • Dovas, A.1    Couchman, J.R.2
  • 22
    • 21744432683 scopus 로고    scopus 로고
    • GDIs: Central regulatory molecules in Rho GTPase activation
    • Der Mardirossian C and Bokoch GM: GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15:356-363, 2005.
    • (2005) Trends Cell Biol , vol.15 , pp. 356-363
    • Der Mardirossian, C.1    Bokoch, G.M.2
  • 23
    • 0026496258 scopus 로고
    • A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs
    • Hart MJ, Maru Y, Leonard D, Witte ON, Evans T and Cerione RA: A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258:812-815, 1992.
    • (1992) Science , vol.258 , pp. 812-815
    • Hart, M.J.1    Maru, Y.2    Leonard, D.3    Witte, O.N.4    Evans, T.5    Cerione, R.A.6
  • 24
    • 0027393663 scopus 로고
    • GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein
    • Chuang TH, Xu X, Knaus UG, Hart MJ and Bokoch GM: GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J Biol Chem 268:775-778, 1993.
    • (1993) J Biol Chem , vol.268 , pp. 775-778
    • Chuang, T.H.1    Xu, X.2    Knaus, U.G.3    Hart, M.J.4    Bokoch, G.M.5
  • 25
    • 65349132693 scopus 로고    scopus 로고
    • EMT, the cytoskeleton, and cancer cell invasion
    • Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28:15-33, 2009.
    • (2009) Cancer Metastasis Rev , vol.28 , pp. 15-33
    • Yilmaz, M.1    Christofori, G.2
  • 26
    • 79960360062 scopus 로고    scopus 로고
    • E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells
    • Theys J, Jutten B, Habets R, et al: E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 99:392-397, 2011.
    • (2011) Radiother Oncol , vol.99 , pp. 392-397
    • Theys, J.1    Jutten, B.2    Habets, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.